You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 67 No. 5, MAY 1941 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PRIMARY BACILLUS FRIEDLÄNDER (KLEBSIELLA PNEUMONIAE) PNEUMONIA

THERAPY OF B. FRIEDLÄNDER B PNEUMONIA

ELY PERLMAN, M.D.; JESSE G. M. BULLOWA, M.D.

Arch Intern Med. 1941;67(5):907-920.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1882 Friedländer1 described a gram-negative, encapsulated bacillus which was at first regarded as the cause of pneumonia. Four years later Weichselbaum2 demonstrated that Diplococcus pneumoniae was the more frequent etiologic agent. Recent extensive studies show that Bacillus Friedländer causes about 0.5 to 4.0 per cent of all the pneumonias and accordingly will be encountered several times a year in any large medical service.

In 1925 Avery, Heidelberger and Goebel3 demonstrated the chemical and immunologic relationship of certain strains of this bacillus to Pneumococcus type II. The following year Julianelle4 classified a number of strains of B. Friedländer by immunologic methods under types A, B and C with a heterologous group X. There are now available the Friedländer bacillus A and the Friedländer bacillus B serum for identification of strains by the Neufeld technic, but the B strain also swells with the type II pneumococcus typing . . . [Full Text PDF of this Article]


Author Affiliations

Clinical Professor of Medicine, New York University College of Medicine; Visiting Physician, Harlem Hospital NEW YORK

From the Medical Service, Harlem Hospital, Department of Hospitals, and the Littauer Pneumonia Research Fund of New York University College of Medicine.


Footnotes

Littauer Fellow in Pneumonia Research.

This study received additional financial support from the Metropolitan Life Insurance Company and from Mr. Bernard M. Baruch. Mr. Bernard M. Baruch Jr., Miss Belle N. Baruch and Mrs. H. Robert Samstag.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1941 American Medical Association. All Rights Reserved.